Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Odero

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Human Genetics|March 4, 2005
FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndromeIdoya Lahortiga, Iria Vázquez, Elena Belloni, et al.
Cancer Research|April 17, 2004
NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorderJosé L Vizmanos, Francisco J Novo, José P Román, et al.
Leukemia|March 23, 2007
DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groupsJ Suela, S Alvarez, F Cifuentes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2014
Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemiaAnupriya Agarwal, Ryan J MacKenzie, Raffaella Pippa, et al.
Cancer Research|June 19, 2004
Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancerRuben Pio, Isabel Zudaire, Irene Pino, et al.
Oncotarget|July 10, 2018
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenibRocio I R Macias, Anabel Sánchez-Martín, Gabriela Rodríguez-Macías, et al.
Cancer Genetics and Cytogenetics|October 24, 2001
Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLLM D Odero, J L Soto, E Matutes, et al.
Journal of Hematology & Oncology|January 11, 2014
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levelsAmy Guillaumet-Adkins, Julia Richter, Maria D Odero, et al.
British Journal of Cancer|September 16, 2010
EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2M Gómez-Benito, A Conchillo, M A García, et al.
Anales Del Sistema Sanitario De Navarra|July 16, 2003
[FICTION as a new tool to early lung cancer diagnosis]I Zudaire, R Pío, I Martín-Subero, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Human Genetics|March 4, 2005
FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndromeIdoya Lahortiga, Iria Vázquez, Elena Belloni, et al.
Cancer Research|April 17, 2004
NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorderJosé L Vizmanos, Francisco J Novo, José P Román, et al.
Leukemia|March 23, 2007
DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groupsJ Suela, S Alvarez, F Cifuentes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2014
Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemiaAnupriya Agarwal, Ryan J MacKenzie, Raffaella Pippa, et al.
Cancer Research|June 19, 2004
Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancerRuben Pio, Isabel Zudaire, Irene Pino, et al.
Oncotarget|July 10, 2018
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenibRocio I R Macias, Anabel Sánchez-Martín, Gabriela Rodríguez-Macías, et al.
Cancer Genetics and Cytogenetics|October 24, 2001
Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLLM D Odero, J L Soto, E Matutes, et al.
Journal of Hematology & Oncology|January 11, 2014
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levelsAmy Guillaumet-Adkins, Julia Richter, Maria D Odero, et al.
British Journal of Cancer|September 16, 2010
EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2M Gómez-Benito, A Conchillo, M A García, et al.
Anales Del Sistema Sanitario De Navarra|July 16, 2003
[FICTION as a new tool to early lung cancer diagnosis]I Zudaire, R Pío, I Martín-Subero, et al.
Pageof 8